AMRX
Price
$12.15
Change
+$0.20 (+1.67%)
Updated
Nov 24, 04:59 PM (EDT)
Capitalization
3.76B
100 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AMRX

Header iconAMRX Comparison
Open Charts AMRXBanner chart's image
Amneal Pharmaceuticals
Price$12.15
Change+$0.20 (+1.67%)
Volume$39.83K
Capitalization3.76B
AMRX Comparison Chart in %
AMRX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are ZOETIS (NYSE:ZTS), Teva Pharmaceutical Industries Limited (NYSE:TEVA), Elanco Animal Health (NYSE:ELAN), Avadel Pharmaceuticals plc (NASDAQ:AVDL), Bausch Health Companies (NYSE:BHC), BioCryst Pharmaceuticals (NASDAQ:BCRX), Tilray Brands (NASDAQ:TLRY), Canopy Growth Corp (NASDAQ:CGC), Aurora Cannabis (NASDAQ:ACB), Journey Medical Corp (NASDAQ:DERM).

Industry description

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

Market Cap

The average market capitalization across the Pharmaceuticals: Generic Industry is 4.09B. The market cap for tickers in the group ranges from 2.12K to 63.66B. AGN holds the highest valuation in this group at 63.66B. The lowest valued company is CANQF at 2.12K.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Generic Industry was 3%. For the same Industry, the average monthly price growth was -6%, and the average quarterly price growth was 16%. RGTLF experienced the highest price growth at 66%, while MAJI experienced the biggest fall at -45%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Generic Industry was -19%. For the same stocks of the Industry, the average monthly volume growth was -25% and the average quarterly volume growth was 27%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 62
Price Growth Rating: 60
SMR Rating: 79
Profit Risk Rating: 90
Seasonality Score: -1 (-100 ... +100)
Interact to see
Advertisement
COMPARISON
Comparison
Nov 25, 2025
Stock price -- (AMRX: $11.95)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMRX’s FA Score shows that 1 FA rating(s) are green while.

  • AMRX’s FA Score: 1 green, 4 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMRX’s TA Score shows that 3 TA indicator(s) are bullish.

  • AMRX’s TA Score: 3 bullish, 5 bearish.

Price Growth

AMRX (@Pharmaceuticals: Generic) experienced а +2.66% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +3.09%. For the same industry, the average monthly price growth was -6.42%, and the average quarterly price growth was +15.67%.

Reported Earning Dates

AMRX is expected to report earnings on Mar 04, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (+3.09% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMRX
Capitalization3.76B
EBITDA584M
Gain YTD50.884
P/E Ratio1195.00
Revenue2.85B
Total Cash71.5M
Total Debt2.58B
FUNDAMENTALS RATINGS
AMRX: Fundamental Ratings
AMRX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
39
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
12
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AMRX
RSI
ODDS (%)
Bearish Trend 4 days ago
70%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
69%
Momentum
ODDS (%)
Bullish Trend 4 days ago
84%
MACD
ODDS (%)
Bearish Trend 4 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
80%
Advances
ODDS (%)
Bullish Trend 14 days ago
81%
Declines
ODDS (%)
Bearish Trend 6 days ago
73%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
78%
Aroon
ODDS (%)
Bullish Trend 4 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
AMRX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VGHCX206.363.94
+1.95%
Vanguard Health Care Inv
AFDGX57.400.60
+1.06%
American Century Large Cap Equity R5
WWNPX116.860.75
+0.65%
Kinetics Paradigm No Load
CZMGX20.140.09
+0.45%
Multi-Manager Growth Strategies Inst
TAGDX15.100.03
+0.20%
Transamerica Large Growth R6

AMRX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AMRX has been loosely correlated with VTRS. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AMRX jumps, then VTRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMRX
1D Price
Change %
AMRX100%
+3.78%
VTRS - AMRX
47%
Loosely correlated
+2.65%
TEVA - AMRX
42%
Loosely correlated
-0.29%
AMPH - AMRX
42%
Loosely correlated
+2.56%
PAHC - AMRX
41%
Loosely correlated
+2.01%
BHC - AMRX
39%
Loosely correlated
+0.50%
More